Table 2.

Cost of testing and treatment* when using an antimicrobial resistance point-of-care test (AMR POCT) for ciprofloxacin resistance (strategy 3a) compared with current practice

	Heterosexual male	MSM	Female	Overall
Annual cost of testing (£)
Current	69 784 517	20 358 694	105 826 467	195 969 677
AMR POCT	82 415 040	23 338 080	124 653 600	230 406 720
Increased cost with AMR POCT	12 630 523	2 979 386	18 827 133	34 437 043

*The model assumes that the additional cost of AMR POCT (£25) is simply added to the cost of attendance and is not offset by reductions in the number of gonorrhoea infections by reduced treatment costs (as some patients are treated with cheaper antibiotics), or by reduced use of other tests (such as microscopy or culture of all swabs).

MSM, men who have sex with men.